In addition, our group has demonstrated that PBAEs can effectively deliver DNA to tumors following local administration in vivo.19, 20 Moreover, the ability to deliver DNA, such as TRAIL, with biomaterial‐mediated cancer cell specificity suggests this system's potential utility in specifically transfecting cancer cells with this therapeutic gene even in an in vivo environment. This evidence concerns the gene TNFSF10 and cancer.